Co-Director, Flinders University International Centre for Point-of-Care Testing (POCT)
Jason Grebely
Head of the Hepatitis C and Drug Use Group in the Viral Hepatitis Clinical Research Program at the Kirby Institute, UNSW, NSW, Australia
Jason leads a research group undertaking research to improve the health of people who use drugs, with a specific focus on hepatitis C infection. His research includes the evaluation of novel strategies (including diagnostic testing) and models of care to enhance linkage to testing and treatment for hepatitis C infection, clinical trials and cohort studies evaluating hepatitis C treatment and reinfection among people who inject drugs, and clinical trials to evaluate hepatitis C treatment as prevention. His research group conducts research which engages with affected communities, practitioners, policy makers, and other stakeholders to impact practice and policy.
Jessica Michaels
Deputy
CEO at ASHM Health
Jessica Michaels is the Deputy CEO at ASHM. Jessicas work at ASHM includes overseeing the implementation of HIV, sexual health, hepatitis C and hepatitis B workforce development, capacity building, resources, strategies and policies across Australia. Jessica has worked in the BBV and sexual health sector for over 15 years, managing a variety of government and non-government education, clinical and health promotion programs in Australia, South Africa, the UK, Papua New Guinea and Singapore.
Lise Lafferty
Senior Research Fellow at UNSW Sydney
Director
of the Global Division at ASHM Health
Tanya Applegate
Senior Lecturer and lead of the Diagnostic Innovations Group within Surveillance Evaluation and Research Program at the Kirby Institute, UNSW Sydney. Scientific Manager of the RAPID Point of Care Research Consortium for accelerating the scale up of point of care testing for infectious disease in the Asia Pacific, and a Co-Director of an ARC Industrial Transformation Research Hub to combat antimicrobial resistance.
Tanya has over 25 years of laboratory and translational research experience within regulatory, hospital, industry and academic environments and is driven by a passion to provide equitable access to health care through simplified diagnostics. Her research focuses on working with stakeholders across industries to accelerate the development, evaluation and implementation of novel infectious disease diagnostics tests for people who are marginalised or living in remote or resource limited settings.
Rebecca Guy
Professor in Epidemiology at the Kirby Institute for infection and immunity in society, Faculty of Medicine, UNSW, NSW, Australia